Several years ago, Anita Turk, MD, assistant professor of clinical medicine at the Indiana University School of Medicine in Indianapolis, was treating a patient with advanced gastrointestinal cancer.

England international Jude Bellingham has urged his Real Madrid teammates to step up ahead of their crucial Champions League quarterfinal second leg against Bayern Munich. After suffering a 1-2 home ...

Belgium and Norway are delaying delivery of 36 F-16s to Ukraine, affecting nearly half of pledged aircraft. Defense Express reports Belgium linked its pause to U.S. F-35 arrival schedules, with the ...

Los Angeles Dodgers starting pitcher Roki Sasaki showed some improvement in LA’s series finale against the Texas Rangers. He finished the game with a final line of four innings pitched, five hits, two ...

LITTLE ROCK, Ark. (KATV) — This is where the speech meets the spreadsheet. The state is entering a constitutionally limited fiscal session, meaning lawmakers don’t get the luxury of open-ended ...

This is an edition of the What’s News newsletter, which helps you catch up on the headlines and understand the news, free in your inbox daily. If you’re not subscribed, sign up here. 1. President ...

President Trump has repeatedly promised his top administration officials pardons before he leaves office, according to people who have heard his comments. “I’ll pardon everyone who has come within 200 ...

He’s Zo-ing back on his word. Many of Mayor Zohran Mamdani’s lofty campaign promises have already bitten the dust 100 days in, as he makes a U-turn or scales them back almost beyond recognition. His ...

Zohran Mamdani based his successful campaign for mayor of New York City on several central pledges. Here’s an early look on where those stand. By Nicholas Fandos Mayor Zohran Mamdani swept into office ...

The Colorado Rockies' top pitching prospect had one of his best outings in uniform, yet was still handed the loss due to the offense's lack of clutchness. The Colorado Rockies got a very encouraging ...

DENVER — A first-in-class oral, selective TYK2-JAK1 inhibitor showed clinical benefit in adults with dermatomyositis who had not responded to prior therapies, in a phase 3, double-blind, randomized, ...